237 related articles for article (PubMed ID: 33583371)
1. Multi-Target Drug Design of Anti-Alzheimer's Disease based on Tacrine.
Tian S; Huang Z; Meng Q; Liu Z
Mini Rev Med Chem; 2021; 21(15):2039-2064. PubMed ID: 33583371
[TBL] [Abstract][Full Text] [Related]
2. Design and synthesis of novel tacrine-dipicolylamine dimers that are multiple-target-directed ligands with potential to treat Alzheimer's disease.
Zhang P; Wang Z; Mou C; Zou J; Xie Y; Liu Z; Benjamin Naman C; Mao Y; Wei J; Huang X; Dong J; Yang M; Wang N; Jin H; Liu F; Lin D; Liu H; Zhou F; He S; Zhang B; Cui W
Bioorg Chem; 2021 Nov; 116():105387. PubMed ID: 34628225
[TBL] [Abstract][Full Text] [Related]
3. Tacrine derivatives and Alzheimer's disease.
Tumiatti V; Minarini A; Bolognesi ML; Milelli A; Rosini M; Melchiorre C
Curr Med Chem; 2010; 17(17):1825-38. PubMed ID: 20345341
[TBL] [Abstract][Full Text] [Related]
4. Tacrine-resveratrol fused hybrids as multi-target-directed ligands against Alzheimer's disease.
Jeřábek J; Uliassi E; Guidotti L; Korábečný J; Soukup O; Sepsova V; Hrabinova M; Kuča K; Bartolini M; Peña-Altamira LE; Petralla S; Monti B; Roberti M; Bolognesi ML
Eur J Med Chem; 2017 Feb; 127():250-262. PubMed ID: 28064079
[TBL] [Abstract][Full Text] [Related]
5. Novel multitarget-directed tacrine derivatives as potential candidates for the treatment of Alzheimer's disease.
Wu WY; Dai YC; Li NG; Dong ZX; Gu T; Shi ZH; Xue X; Tang YP; Duan JA
J Enzyme Inhib Med Chem; 2017 Dec; 32(1):572-587. PubMed ID: 28133981
[TBL] [Abstract][Full Text] [Related]
6. Recent Developments in Tacrine-based Hybrids as a Therapeutic Option for Alzheimer's Disease.
Yamali C; Donmez S
Mini Rev Med Chem; 2023; 23(7):869-880. PubMed ID: 36464869
[TBL] [Abstract][Full Text] [Related]
7. Quinolinetrione-tacrine hybrids as multi-target-directed ligands against Alzheimer's disease.
Uliassi E; Bergamini C; Rizzardi N; Naldi M; Cores Á; Bartolini M; Carlos Menéndez J; Bolognesi ML
Bioorg Med Chem; 2023 Aug; 91():117419. PubMed ID: 37487339
[TBL] [Abstract][Full Text] [Related]
8. Cystamine-tacrine dimer: a new multi-target-directed ligand as potential therapeutic agent for Alzheimer's disease treatment.
Minarini A; Milelli A; Tumiatti V; Rosini M; Simoni E; Bolognesi ML; Andrisano V; Bartolini M; Motori E; Angeloni C; Hrelia S
Neuropharmacology; 2012 Feb; 62(2):997-1003. PubMed ID: 22032870
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, biological evaluation and molecular modeling study of novel tacrine-carbazole hybrids as potential multifunctional agents for the treatment of Alzheimer's disease.
Thiratmatrakul S; Yenjai C; Waiwut P; Vajragupta O; Reubroycharoen P; Tohda M; Boonyarat C
Eur J Med Chem; 2014 Mar; 75():21-30. PubMed ID: 24508831
[TBL] [Abstract][Full Text] [Related]
10. Tacrine-based Multifunctional Agents in Alzheimer's Disease: An Old Story in Continuous Development§.
Milelli A; De Simone A; Ticchi N; Chen HH; Betari N; Andrisano V; Tumiatti V
Curr Med Chem; 2017; 24(32):3522-3546. PubMed ID: 28294041
[TBL] [Abstract][Full Text] [Related]
11. Dimeric Tacrine(10)-hupyridone as a Multitarget-Directed Ligand To Treat Alzheimer's Disease.
Xuan Z; Gu X; Yan S; Xie Y; Zhou Y; Zhang H; Jin H; Hu S; Mak MSH; Zhou D; Keung Tsim KW; Carlier PR; Han Y; Cui W
ACS Chem Neurosci; 2021 Jul; 12(13):2462-2477. PubMed ID: 34156230
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic Agents in Alzheimer's Disease Through a Multi-targetdirected Ligands Strategy: Recent Progress Based on Tacrine Core.
Lin H; Li Q; Gu K; Zhu J; Jiang X; Chen Y; Sun H
Curr Top Med Chem; 2017; 17(27):3000-3016. PubMed ID: 28714419
[TBL] [Abstract][Full Text] [Related]
13. Tacrine-Based Hybrids: Past, Present, and Future.
Bubley A; Erofeev A; Gorelkin P; Beloglazkina E; Majouga A; Krasnovskaya O
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675233
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and biological activity of novel tacrine-isatin Schiff base hybrid derivatives.
Riazimontazer E; Sadeghpour H; Nadri H; Sakhteman A; Tüylü Küçükkılınç T; Miri R; Edraki N
Bioorg Chem; 2019 Aug; 89():103006. PubMed ID: 31158577
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and evaluation of novel tacrine-(β-carboline) hybrids as multifunctional agents for the treatment of Alzheimer's disease.
Lan JS; Xie SS; Li SY; Pan LF; Wang XB; Kong LY
Bioorg Med Chem; 2014 Nov; 22(21):6089-104. PubMed ID: 25282654
[TBL] [Abstract][Full Text] [Related]
16. Tacrine-flurbiprofen hybrids as multifunctional drug candidates for the treatment of Alzheimer's disease.
Chen Y; Sun J; Peng S; Liao H; Zhang Y; Lehmann J
Arch Pharm (Weinheim); 2013 Dec; 346(12):865-71. PubMed ID: 24203864
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic Potential of Multifunctional Tacrine Analogues.
Przybyłowska M; Kowalski S; Dzierzbicka K; Inkielewicz-Stepniak I
Curr Neuropharmacol; 2019; 17(5):472-490. PubMed ID: 29651948
[TBL] [Abstract][Full Text] [Related]
18. A Review on Recent Development of Novel Heterocycles as Acetylcholinesterase Inhibitor for the Treatment of Alzheimer's Disease.
Patel A; Shah D; Patel Y; Patel S; Mehta M; Bambharoliya T
Curr Drug Targets; 2023; 24(3):225-246. PubMed ID: 36515018
[TBL] [Abstract][Full Text] [Related]
19. Novel anti-Alzheimer's dimer Bis(7)-cognitin: cellular and molecular mechanisms of neuroprotection through multiple targets.
Li W; Mak M; Jiang H; Wang Q; Pang Y; Chen K; Han Y
Neurotherapeutics; 2009 Jan; 6(1):187-201. PubMed ID: 19110209
[TBL] [Abstract][Full Text] [Related]
20. Multitarget Tacrine Hybrids with Neuroprotective Properties to Confront Alzheimer's Disease.
Spilovska K; Korabecny J; Nepovimova E; Dolezal R; Mezeiova E; Soukup O; Kuca K
Curr Top Med Chem; 2017; 17(9):1006-1026. PubMed ID: 27697055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
